Search Within

Lindsay Van Alstine

  1. "Advanced Practice Providers"
Formats
  1. Meeting Abstract (4)
  2. Journal Article (1)
Groups
  1. Advanced Practice Providers (5)
  2. Biostatistics Service (5)
  3. Department of Medicine (5)
  4. Epidemiology and Biostatistics (5)
  5. Genitourinary Oncology Service (5)
  6. Nursing (5)

More Groups

People
  1. Amanda Hughes (5)
  2. Darren Feldman (5)
  3. Dean Bajorin (5)
  4. George Bosl (5)
  5. Joel Sheinfeld (5)
  6. Manjit Bains (5)

More People

Years
  1. 2015 (1)
  2. 2014 (1)
  3. 2013 (3)
Publications
  1. Journal of Clinical Oncology (3)
  2. Biology of Blood and Marrow Transplantation (1)
  3. Clinical Genitourinary Cancer (1)
Publishers
  1. American Society of Clinical Oncology (3)
  2. Elsevier Inc. (2)

Results (5)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase I/II trial of paclitaxel with ifosfamide followed by high-dose paclitaxel, ifosfamide, and carboplatin (TI-TIC) with autologous stem cell reinfusion for salvage treatment of germ cell tumors
    Journal Article

    Feldman, D. R.; Glezerman, I.; Patil, S.; Van Alstine, L.; Bajorin, D. F.; Fischer, P.; Hughes, A.; Sheinfeld, J.; Bains, M.; Reich, L.; more...
    Clinical Genitourinary Cancer (2015)

    Fulltext@MSK | Save
  • Phase I/II study of paclitaxel plus ifosfamide followed by high-dose paclitaxel, ifosfamide, and carboplatin with autologous stem cell reinfusion for salvage treatment of germ cell tumors
    Meeting Abstract

    Feldman, D. R.; Glezerman, I.; Patil, S.; Van Alstine, L.; Bajorin, D. F.; Fischer, P.; Hughes, A.; Sheinfeld, J.; Bains, M.; Reich, L.; more...
    Biology of Blood and Marrow Transplantation (2014)

    Fulltext@MSK | Save
  • Phase II trial of paclitaxel, ifosfamide, and cisplatin (TIP) for previously untreated patients (pts) with intermediate- or poor-risk germ cell tumors (GCT)
    Meeting Abstract

    Feldman, D. R.; Hu, J.; Dorff, T. B.; Patil, S.; Van Alstine, L. J.; Momen, L.; Carousso, M.; Hughes, A.; Snively-Solomon, J.; Ketchens, C.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Phase I/II study of paclitaxel plus ifosfamide (TI) followed by high-dose paclitaxel, ifosfamide, and carboplatin (TIC) with autologous stem cell transplant (ASCT) for salvage treatment of germ cell tumors (GCT)
    Meeting Abstract

    Jia, X.; Feldman, D. R.; Glezerman, I.; Van Alstine, L. J.; Bajorin, D. F.; Fischer, P.; Hughes, A.; Sheinfeld, J.; Bains, M. S.; Reich, L.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Paclitaxel, ifosfamide, and cisplatin (TIP) efficacy for first-line treatment of patients (pts) with intermediate- or poor-risk germ cell tumors (GCT)
    Meeting Abstract

    Feldman, D. R.; Hu, J.; Dorff, T. B.; Patil, S.; Van Alstine, L. J.; Momen, L.; Carousso, M.; Hughes, A.; Snively-Solomon, J.; Ketchens, C.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save